Active Ingredient(s): Inamrinone
FDA Approved: * July 31, 1984
Pharm Company: * SANOFI AVENTIS US
Category: Heart (Cardiac)

Amrinone, also known as inamrinone, and sold as Inocor, is a pyridine phosphodiesterase 3 inhibitor.[1] It is a drug that may improve the prognosis in patients with congestive heart failure.[2] Amrinone has been shown to increase the contractions initiated in the heart by high-gain calcium induced calcium release (CICR).[3] The positive inotropic effect of amrinone is mediated by the selective enhancement of high-gain CICR, which contributes to... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.